510(k) Report

510(k) · Cleared

Cleared

TK1 Total Knee System

K123339510(k) TraditionalCleared Apr 11, 2013162-day reviewClass II21 CFR 888.3560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Novosource, Inc. · JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer

Cleared on Apr 11, 2013 as substantially equivalent to K051640 (United Orthopedic Corp., 2006) after a 162-day review. Its family tree reaches back 2 generations to 2002. 11 later devices descend from it.

Decided
Apr 11, 2013
Review
162 days
Class
Class II
Product code
JWH
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K021657 (2002). 11 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared2018: 3 descendants cleared2015: 1 descendant cleared2026: 1 descendant cleared2023: 1 descendant cleared2019: 3 descendants cleared2021: 1 descendant clearedK021657 · Uknee Total Knee System · United Orthopedic Corp. · 2002K051640 · U2 Total Knee System · United Orthopedic Corp. · 2006 · recalled200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 5 descendants3 generations forward: 4 descendants K051640 · U2 Total Knee System · United Orthopedic Corp. · 2006 · recalledK021657 · Uknee Total Knee System · United Orthopedic Corp. · 20020
  1. Root · 2 generations backK021657 Uknee Total Knee SystemUnited Orthopedic Corp. · 2002
  2. 1 generation backK051640 U2 Total Knee SystemUnited Orthopedic Corp. · 2006 · Recalled
  3. This deviceK123339 TK1 Total Knee SystemNovosource, Inc. · 2013
  4. Descendant · cites it directly · 10 of its ownK131398 Novoknee Total Knee SystemNovosource, Inc. · 2013
  5. Descendant · 2 generations on · 8 of its ownK150783 Progressive Orthopaedic Total Knee SystemThe Progressive Orthopaedic Company, LLC · 2015
  6. Descendant · cites it directly · 3 of its ownK170753 Acculoc Total Knee SystemRootloc Co., Ltd. · 2018
  7. Descendant · 2 generations on · 0 of its ownK261032 NovoKnee (SteriKnee)NovoSource · 2026
  8. Descendant · 2 generations on · 0 of its ownK231975 PNK Total Knee SystemTjc Life Co., Ltd. · 2023

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2013: 12015: 12018: 32019: 32021: 12023: 12026: 1
2013high 3 (2018) · low 0 (2014)2026

Most influential descendants

Showing 5 of 11 · See all
  • K131398Novoknee Total Knee SystemNovosource, Inc. · 2013 · cites it directly10descendants
  • K150783Progressive Orthopaedic Total Knee SystemThe Progressive Orthopaedic Company, LLC · 2015 · 2 generations on8descendants
  • K170753Acculoc Total Knee SystemRootloc Co., Ltd. · 2018 · cites it directly3descendants
  • K261032NovoKnee (SteriKnee)NovoSource · 2026 · 2 generations on0descendants
  • K231975PNK Total Knee SystemTjc Life Co., Ltd. · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K021657Uknee Total Knee SystemUnited Orthopedic Corp.2002—
−1K051640U2 Total Knee SystemUnited Orthopedic Corp.20061
0 (this device)K123339TK1 Total Knee SystemNovosource, Inc.2013—
+1K131398Novoknee Total Knee SystemNovosource, Inc.2013—
+2K150783Progressive Orthopaedic Total Knee SystemThe Progressive Orthopaedic Company, LLC2015—
+1K170753Acculoc Total Knee SystemRootloc Co., Ltd.2018—
+2K261032NovoKnee (SteriKnee)NovoSource2026—
+2K231975PNK Total Knee SystemTjc Life Co., Ltd.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201510
201830
201930
202110
202310
202610
FIG. 1 — Lineage of K123339, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JWH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JWH device

  1. #1 K221479 Persona Personalized Knee Systemscore 22.4 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051640U2 Total Knee System
Summary page 1
…r the Orthopedics panel/87 as a Class 11device. Device Product Code: .IWH Predicate Device: U2 Total Knee System (K051640) Device Description: The NovaKnee Total Knee System is of the fixed bearing type with a posterior stabilized design. It is a…
United Orthopedic Corp.20061

Also cleared against K051640: 15 other devices →

What descends from it? (11)

See all 11

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K131398Novoknee Total Knee SystemNovosource, Inc.201310
K170753Acculoc Total Knee SystemRootloc Co., Ltd.20183

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 2 companies; a new generation was cleared every 7.1 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K131398 (Novosource, Inc., 2013) has gone furthest, with 10 descendants of its own.
  • 15 other devices also cite its predicate K051640.

How does its category compare?

All JWH devices

JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · JWH

20in 2025

2007: 182008: 172009: 112010: 192011: 252012: 332013: 312014: 332015: 272016: 182017: 252018: 252019: 282020: 222021: 242022: 172023: 202024: 192025: 202026 (partial year): 12
2007high 33 (2012) · low 11 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JWH

55in 2025

2007: 74 days median2008: 81 days median2009: 168 days median2010: 85 days median2011: 87 days median2012: 85 days median2013: 128 days median2014: 98 days median2015: 87 days median2016: 88 days median2017: 118 days median2018: 90 days median2019: 133 days median2020: 59 days median2021: 61 days median2022: 56 days median2023: 57 days median2024: 89 days median2025: 55 days median2026 (partial year): 63 days median
2007high 168 (2009) · low 55 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JWH

2in 2025

2007: 142008: 102009: 1092010: 322011: 272012: 852013: 312014: 132015: 112016: 172017: 612018: 142019: 52020: 22021: 82022: 122023: 672024: 72025: 22026 (partial year): 4
2007high 109 (2009) · low 2 (2020)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JWH

9,306in 2025

2007: 1,3052008: 1,4832009: 1,8702010: 3,2862011: 5,1332012: 5,2032013: 6,1352014: 6,7222015: 6,8812016: 7,5862017: 12,2632018: 14,0712019: 14,9872020: 12,5922021: 9,4082022: 8,3642023: 8,9472024: 10,8282025: 9,306
2007high 14,987 (2019) · low 1,305 (2007)2025

MAUDE reports naming product code JWH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071874141,305
20081781101,483
2009111681091,870
20101985323,286
20112587275,133
20123385855,203
201331128316,135
20143398136,722
20152787116,881
20161888177,586
2017251186112,263
201825901414,071
201928133514,987
20202259212,592
2021246189,408
20221756128,364
20232057678,947
20241989710,828
2025205529,306
202612634—

What is it indicated for?

The NovoKnee Total Knee System is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with severe knee pain and disability due to rheumatoid arthritis, osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle or pseudogout, posttraumnatic loss of joint configuration, particularly when there is…

Read the full statement (113 words)

The NovoKnee Total Knee System is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with severe knee pain and disability due to rheumatoid arthritis, osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle or pseudogout, posttraumnatic loss of joint configuration, particularly when there is patellofemoral erosion. dysfunction or prior patellectomy, moderate valgus. or flexion deformities. The NovoKnee Total Knee System may also be indicated in the salvage of previously failed surgical attempts if the knee can be satisfactorily balanced and stabilized at the time of surgery. The NovoKnee Total Knee System is designed for cemented use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123339: TK1 Total Knee System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K123339

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026